In ESCC cells, lysyl oxidase-like 2 (LOXL2) upregulates the phosphorylation of Ezrin to promote cytoskeletal reorganization and cell invasion [222]. The gene discussed is LOXL2; the disease is esophageal squamous cell carcinoma.